Thrombolytic therapy for pulmonary embolism: reversal of shock in the early postoperative period.

Abstract

Life-threatening acute pulmonary embolism (PE) associated with circulatory shock requires effective therapy directed at removing the obstruction to flow in the pulmonary vasculature and improving hemodynamics. Options for treatment are pulmonary embolectomy and thrombolytic therapy. Although safe and effective, thrombolytic therapy is relatively contraindicated within 10 days of major surgery due to the risk of bleeding. Intravenous streptokinase was administered to a man on the third postoperative day for treatment of a massive PE associated with circulatory shock. Within 2 hours of initiating therapy, the patient experienced marked improvement in hemodynamics and tissue perfusion. No bleeding complications were noted. This case demonstrates that intravenous thrombolytics may be administered safely to patients who have recently undergone surgery. It also underscores that the decision to apply the therapy when relatively contraindicated must be made on an individual patient basis and thus ensure that potentially life-saving therapy is not withheld from those who require it most.

• Authors: S A Nasraway, N Kabani, K R Lawrence
• Journal: Pharmacotherapy (Pharmacotherapy) 1994 Sep-Oct Vol. 14 Issue 5 Pg. 616-9 ISSN: 0277-0008 [Print] United States
• PMID: 7997397 (Publication Type: Case Reports, Comparative Study, Journal Article)

Chemical References

• Streptokinase

Topics

• Acute Disease
• Aged
• Humans
• Injections, Intravenous
• Intensive Care Units
• Male
• Postoperative Period
• Pulmonary Embolism (drug therapy)
• Shock (therapy)
• Streptokinase (therapeutic use)
• Thrombolytic Therapy